The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I first-in-human clinical trial with PLZ4-coated paclitaxel-loaded micelles (PPM) in therapy-resistant non-muscle-invasive bladder cancer (NMIBC).
 
Chong-xian Pan
Stock and Other Ownership Interests - Accelerated Medical Diagnostics; LP Therapeutics; Pandomedx
 
Juan Garisto
No Relationships to Disclose
 
Lori Lerner
No Relationships to Disclose
 
Matthew Mossanen
No Relationships to Disclose
 
Marc Dall'Era
No Relationships to Disclose
 
Hizra Farrukh
No Relationships to Disclose
 
Colleen Hynes
No Relationships to Disclose
 
Mamta Parikh
Consulting or Advisory Role - Bristol Myers Squibb; Pfizer; Pfizer-Myovant; Sanofi/Aventis; Totus Medicines
Research Funding - Gilead Sciences; Karyopharm Therapeutics (Inst)
 
Primo Lara
Consulting or Advisory Role - Genmab
Research Funding - AstraZeneca (Inst)
 
Urvashi Bhardwaj
No Relationships to Disclose
 
Ai-Hong Ma
No Relationships to Disclose
 
Joyce Lee
No Relationships to Disclose
 
Yuanpei Li
Stock and Other Ownership Interests - LP Therapeutics
 
Tzu-yin Lin
Stock and Other Ownership Interests - LP Therapeutics
 
Yanxiao Jiao
No Relationships to Disclose
 
Junwei Zhao
No Relationships to Disclose
 
Ruiwu Liu
No Relationships to Disclose
 
Kit Lam
Leadership - Lamno Therapeutics
Stock and Other Ownership Interests - Lamno Therapeutics; LP Therapeutics